PMID- 2555395 OWN - NLM STAT- MEDLINE DCOM- 19900108 LR - 20200409 IS - 0165-5728 (Print) IS - 1872-8421 (Electronic) IS - 0165-5728 (Linking) VI - 25 IP - 2-3 DP - 1989 Dec TI - Tumor necrosis factor-alpha enhances interferon-gamma-mediated class II antigen expression on astrocytes. PG - 209-19 AB - Astrocytes can function as antigen-presenting cells (APC) upon expression of class II antigens, which are induced by interferon-gamma (IFN-gamma). Tumor necrosis factor-alpha (TNF-alpha) can act synergistically with IFN-gamma with respect to class II expression on a variety of cells. As brain cells themselves can secrete TNF-like factors upon stimulation, we examined the effect of TNF-alpha on IFN-gamma-mediated class II induction on astrocytes. TNF-alpha alone had no effect on class II expression, but did synergize with IFN-gamma for enhanced expression of class II antigens. The specificity of TNF-alpha activity was demonstrated by blocking the amplifying effect of TNF-alpha with a polyclonal anti-TNF-alpha antibody. Kinetic analysis of the synergistic effect indicated that optimal TNF-alpha enhancement of class II expression was observed when astrocytes were pretreated with IFN-gamma 12-24 h prior to TNF-alpha addition. A possible mechanism for the synergistic action between IFN-gamma and TNF-alpha may be increased TNF-alpha receptor expression by IFN-gamma. Astrocytes treated with IFN-gamma for 24 h express more TNF-alpha receptors (3900/cell) than do untreated astrocytes (2483/cell), with no significant change in the binding affinity (Kd). These results suggest that the synergistic activity of TNF-alpha requires an inductive signal from IFN-gamma, which in part may be increased TNF-alpha receptor expression. Altogether, our observations indicate that TNF-alpha enhances ongoing class II major histocompatibility complex gene expression in rat astrocytes, which in this system is initially induced by IFN-gamma. TNF-alpha exerts its effect by binding to high affinity TNF-alpha receptors on astrocytes, whose expression is also enhanced by IFN-gamma. These two cytokines work in concert to elevate class II expression on astrocytes, an event which can contribute to initiation and/or perpetuation of intracerebral immune responses. FAU - Benveniste, E N AU - Benveniste EN AD - Department of Neurology, University of Alabama, Birmingham 35294. FAU - Sparacio, S M AU - Sparacio SM FAU - Bethea, J R AU - Bethea JR LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, Non-P.H.S. PL - Netherlands TA - J Neuroimmunol JT - Journal of neuroimmunology JID - 8109498 RN - 0 (Histocompatibility Antigens Class II) RN - 0 (Receptors, Cell Surface) RN - 0 (Receptors, Tumor Necrosis Factor) RN - 0 (Tumor Necrosis Factor-alpha) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Animals MH - Astrocytes/*immunology/metabolism MH - Histocompatibility Antigens Class II/*immunology MH - Interferon-gamma/*pharmacology MH - Kinetics MH - Receptors, Cell Surface/metabolism MH - Receptors, Tumor Necrosis Factor MH - Tumor Necrosis Factor-alpha/metabolism/*pharmacology PMC - PMC7119699 EDAT- 1989/12/01 00:00 MHDA- 2000/06/01 09:00 PMCR- 2002/11/11 CRDT- 1989/12/01 00:00 PHST- 1989/12/01 00:00 [pubmed] PHST- 2000/06/01 09:00 [medline] PHST- 1989/12/01 00:00 [entrez] PHST- 2002/11/11 00:00 [pmc-release] AID - 0165-5728(89)90139-2 [pii] AID - 10.1016/0165-5728(89)90139-2 [doi] PST - ppublish SO - J Neuroimmunol. 1989 Dec;25(2-3):209-19. doi: 10.1016/0165-5728(89)90139-2.